Raberger G, Krumpl G, Fischer G, Grohs J G, Todt H, Krejcy K, Huber S, Brugger G, Karel A, Krivanek P
Pharmakologisches Institut, Universität Wien.
Wien Klin Wochenschr. 1990 Oct 26;102(20):593-601.
Like all other scientific disciplines, preclinical pharmacological research is subject to permanent changes. New measuring devices and the possibility of continuous on line data acquisition have markedly influenced basic research in this field. Another aim of modern cardiovascular pharmacology is the testing of promising drugs in clinically relevant animal models of disease, particularly under conditions, referring to the everyday situation in patients, e.g. physical activity. Investigations carried out in this way allow an exact assessment of the clinical efficacy of new drugs, and are, thus, clearly indispensable, also from the ethical point of view, before primary evaluation of the drug in man.
与所有其他科学学科一样,临床前药理学研究也在不断变化。新的测量设备以及连续在线数据采集的可能性显著影响了该领域的基础研究。现代心血管药理学的另一个目标是在临床相关的疾病动物模型中测试有前景的药物,特别是在模拟患者日常情况(如身体活动)的条件下进行测试。以这种方式进行的研究能够准确评估新药的临床疗效,因此,从伦理角度来看,在对药物进行人体初步评估之前,这些研究显然也是必不可少的。